DrGuido.ai Presents Breakthrough AI Doctor App at AI*Festival in Milan

Milan, Italy - February 16, 2023 - DrGuido.ai, the innovative AI-driven healthcare startup, concluded its first public presentation at the AI*Festival in Milan on February 15th. The two-day event witnessed overwhelming interest and curiosity from the audience regarding the AI Doctor mobile app. With over 250 inquiries and 150 AI Doctor tests conducted on the website www.drguido.ai, the response was beyond expectations.

Most attendees were drawn to the first B2C application of generative artificial intelligence. Many questions revolved around privacy and how the medical sector would perceive this type of innovation. In summary, the event gathered many confirmations of the strategic key points presented by the mobile app: 1) native Zero Party Data in terms of privacy, 2) central focus on empathy rather than medical knowledge, 3) not a healthcare support but a tool for engaging with consumers on healthcare topics, 4) tool for summarizing requests to forward to healthcare professionals, where DrGuido offers the option to send a summary to the primary care physician at the end of the user interaction, 5) focus on Pre-Diagnosis results rather than diagnosis, with Pre-Diagnosis representing a hypothesis of identified problems based on provided information, 6) in every Pre-Diagnosis, DrGuido always suggests contacting a doctor or specialist for a diagnosis and potential prescription of medication or treatment, 7) proposed price of the premium version €4.97, accessible and excellent for services offered, such as SecondOpinion, which, by uploading a document like an analysis or diagnosis, produces a detailed description always with an empathetic tone towards the individual user. SmartScan, which, with a photo of a medication, provides a comprehensive and empathetic description of the medication, indicating its purpose, how to use it, and any contraindications.

In conclusion, DrGuido is not a medical or telemedicine support but an empathetic response tool to user questions. The event audience strongly affirmed that DrGuido represents an initial demonstration of how Generative Artificial Intelligence can be a tool that will benefit people of all ages, rather than posing a danger to humanity. There were also many proposals for collaboration and partnerships, including potential investors interested in DrGuido as a tool for countries in the developing world, where access to medical services is almost nonexistent. In short, all the conditions are in place for a great success and a case of a highly successful startup at the international level.